肝性胸水临床研究进展与挑战  

Advances and challenges in clinical research on hepatic hydrothorax

作　　者：马博 尚天玲 黄剑洁 涂芷馨 王妍[1] 韩雨金 温晓玉[1] 金清龙[1] MA Bo;SHANG Tianling;HUANG Jianjie;TU Zhixin;WANG Yan;HAN Yujin;WEN Xiaoyu;JIN Qinglong(Department of Hepatology,The First Hospital of Jilin University,Changchun 130021,China;Department of Neurology,The First Hospital of Jilin University,Changchun 130021,China)

机构地区：[1]吉林大学第一医院肝胆胰内科,长春130021 [2]吉林大学第一医院神经内科,长春130021

出　　处：《临床肝胆病杂志》2022年第2期452-456,共5页Journal of Clinical Hepatology

基　　金：国家自然科学基金(81270484);吉林省财政厅项目(JLSCZD2019-027)。

摘　　要：肝性胸水(HH)是肝硬化与门静脉高压相关的一种极具挑战性的并发症,其发生机制及治疗措施仍不完全明确。总结评述了HH的发病机制、临床表现、诊断治疗等方面最新研究进展与挑战,并提供一个多学科的治疗策略,包括减少腹水的产生、防止积液进入胸腔、胸腔积液清除、胸膜腔闭塞和肝移植5部分,以期为更多临床医生提供参考。Hepatic hydrothorax(HH)is a challenging complication of liver cirrhosis associated with portal hypertension,and its pathogenesis and therapeutic measures remain unknown.This article summarizes and reviews the advances and challenges in the research on the pathogenesis,clinical manifestations,diagnosis,and treatment of HH and proposes a multidisciplinary treatment strategy,including reducing the production of ascites,preventing effusion from entering the thoracic cavity,removing pleural effusion,occluding the pleural cavity,and performing liver transplantation,so as to provide a reference for more clinicians.

关 键 词：肝硬化 胸水 腹水 积脓 胸腔 

分 类 号：R575.2[医药卫生—消化系统]